However, both AMPK activators synergistically potentiated RocA-induced ERK-dependent luciferase production in NRAS-mutated MelJuso melanoma cells, where the maximal luciferase activity was approximately 300-fold higher than the activity observed in untreated controls. Here, MAPK1 is linked to melanoma.